安庆奇创药业有限公司

安庆奇创药业有限公司

安徽省安庆市安徽省安庆市高新技术产业开发区纬一路8号

2008

100至149

1,000,000至1,999,999

　　安庆奇创药业有限公司(ANQING CHICO)是一家专业从事医药原料药CDMO服务及高端医药中间体生产的高新技术企业。公司自成立以来，始终专注于小分子靶向抗肿瘤、抗糖尿病、抗心脑血管等“替尼、列汀、列净、沙班”系列医药中间体的研发和生产。 　　生产基地位于国家级高新区——安徽省安庆高新技术开发区，总投资近2亿元人民币，建筑面积约15000平方米。规划建设有2栋各三层的甲类厂房，共6个车间，其中2个车间为高端医药中间体生产车间，4个车间为API(化工级别)GMP生产车间，提供CDMO服务。1个丙类仓库、1个甲类仓库、日处理300吨污水处理站1座及完善的EHS体系。 　　研发中心位于南京市栖霞区仙林大学城纬地路9号江苏生命科技创新园，建筑面积1000平方米，拥有一支经验丰富、充满活力的研发团队。技术人员30人左右，其中研发部20余人，质量部10余人；拥有20多个通风橱、2个公斤级中试实验室、液相色谱、气相、液质、多功能滴定仪、旋光仪、紫外分光光度计、自动熔点仪、快速水分仪、稳定性试验箱等。按照要求配备了网络版数据审计追踪系统，先后通过了ISO9001质量体系认证，ISO14001环境管理体系认证，ISO45001职业健康安全管理体系认证，符合原料药注册申报法规要求。

品牌,生产能力,产品线丰富,接受买家的规格要求,良好的信誉,优质服务

246000

http://www.chicopharm.cn/

公司坚持创新发展战略，注重企业科技创新能力的打造;以研发为驱动，不断加大研发投入，现有员工90余人，已成功开发60多个项目，其中重点项目有：列净系列产品：达格列净、恩格列净、卡格列净、伊格列净、鲁格列净...等列汀系列产品：利格列汀、阿格列汀、曲格列汀、替格列汀、西格列汀...等沙班系列产品：阿哌沙班、利伐沙班、艾多沙班...等替尼系列产品：伊布替尼、泽布替尼、阿卡替尼、培唑帕尼、奥希替尼、吉非替尼、厄洛替尼、伊马替尼、尼洛替尼、阿法替尼、达可替尼、拉帕替尼、阿昔替尼、泊那替尼、呋喹替尼、布格替尼...等其他医药产品：非奈利酮、艾拉莫德、萘莫司他、恩塞芬汀、米拉贝隆、瑞美替罗...等

制造商,出口商

北美洲,中/南美洲,西欧,东欧,亚洲

Imatinib Mesylate;Dasatinib Monohydrate;Nilotinib Hydrochloride Monohydrate;Ibrutinib;Gefitinib;Erlotinib Hydrochloride;Afatinib Dimaleate;Osimertinib Mesylate;Linagliptin;Alogliptin Benzoate;Trelagliptin Succinate;Canagliflozin Hemihydrate;Dapagliflozin Propanediol monohydrate;Empagliflozin;Apixaban;Rivaroxaban;Crizotinib;Ceritinib;Sorafenib Tosylate;Lenvatinib Mesylate;Vandetanib;Sunitinib Malate;Cabozantinib Malate;Pazopanib Hydrochloride;Axitinib;Nintedanib Esylate;Palbociclib;Lapatinib Ditosylate;Relugolix;Regorafenib Monohydrate;Imatinib Mesylate;Dasatinib Monohydrate;Nilotinib Hydrochloride Monohydrate;Ibrutinib;Gefitinib;Erlotinib Hydrochloride;Afatinib Dimaleate;Osimertinib Mesylate;Crizotinib;Ceritinib;Sorafenib Tosylate;Lenvatinib Mesylate;Vandetanib;Sunitinib Malate;Cabozantinib Malate;Pazopanib Hydrochloride;Axitinib;Nintedanib Esylate;Palbociclib;Lapatinib Ditosylate;Relugolix;Regorafenib Monohydrate;Linagliptin;Alogliptin Benzoate;Trelagliptin Succinate;Canagliflozin Hemihydrate;Dapagliflozin Propanediol monohydrate;Empagliflozin;Apixaban;Rivaroxaban;5-Bromo-2-chlorobenzoic acid;(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone;4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene;2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate;2-Chloro-5-iodobenzoic acid;(S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran;(S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol tetraacetate;(S)-(+)-3-Hydroxytetrahydrofuran;2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene;2-(4-Fluorophenyl)-5-[(5-bromo-2-methylphenyl)methyl]thiophene;2-(4-Fluorophenyl)thiophene;5-Bromo-2-methylbenzoic acid;5-Iodo-2-methylbenzoic acid;2-(5-Bromo-2-fluorobenzyl)benzobthiophene;1-(4-Ethoxybenzyl)-5-iodo-4-methoxy-2-methylbenzene;1-Bromo-5-(4-ethoxybenzyl)-2-methoxy-4-methylbenzene;6-Chloro-3-methyluracil;(R)-3-aminopiperidine dihydrochloride;8-Bromo-3-methyl-3,9-dihydro-1H-purine-2,6-dione;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione;2-(Chloromethyl)-4-methylquinazoline;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;(R)-3-(Boc-Amino)piperidine;4-(4-Aminophenyl)morpholin-3-one;(S)-(+)-N-(2,3-Epoxypropyl)phthalimide;5-Chlorothiophene-2-carboxylic acid;5-Chlorothiophene-2-carbonyl chloride;5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride;Ethyl 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate hydrochloride;tert-Butyl [(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate oxalate;3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one;3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one;1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one;3-Morpholino-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydropyridin-2(1H)-one;Ethyl 2-chloro-2-[2-(4-methoxyphenyl)hydrazineylidene]acetate;Ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate;4-Aminobenzonitrile;N-(4-Cyanophenyl)glycine;Ethyl 3-[3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido]propanoate;2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone;5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-one hydrochloride;4,5,6,7-Tetrahydrothieno[3,2-c]pyridine hydrochloride;3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;4-Phenoxybenzoic acid;4-Phenoxyphenylboronic acid;4-Amino-3-iodopyrazolo[3,4-d]pyrimidine;tert-butyl (S)-3-hydroxypiperidine-1-carboxylate;4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline;3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline;1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid;5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid;5-Fluoroindolin-2-one;2,3-Dimethyl-2H-indazol-6-amine hydrochloride;N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine;3-Amino-6-methylbenzenesulfonamide;4-Fluoro-2-methoxy-5-nitroaniline;3-(2-Chloropyrimidin-4-yl)-1-methylindole;4-Hydroxy-6,7-dimethoxyqunioline;3-Chloro-4-(3-fluorobenzyloxy)aniline;6-Iodoquinazolin-4-one;N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine;(5-Formylfuran-2-yl)boronic acid;5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde;6-Iodo-1H-indazole;(E)-6-Nitro-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole;tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate;[5-Bromo-3-[(1R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-yl]amine;Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate hydrochloride;6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one;3-Aminophenylacetylene;4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile;2,4-Dichloro-5-methoxyaniline;2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide;3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate;4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile;N-(3-Chloropropyl)morpholine;4-Chloro-7-methoxyquinoline-6-carboxamide;4-Amino-3-chlorophenol hydrochloride;4-Amino-3-chlorophenol;6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one;tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate;N-(4-Aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide;Methyl 2-oxoindole-6-carboxylate;(3-Oxo-1,3-dihydro-isobenzofuran-1-yl)-phosphonic acid dimethyl ester;2-Fluoro-5-formylbenzonitrile;N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine;3-Amino-2,6-piperidinedione hydrochloride;N-(4-glycyl-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride;4''-(Pentyloxy)-[1,1':4',1''-terphenyl]-4-carboxylic acid;4-[5-(4-Pentyloxyphenyl)isoxazol-3-yl]benzoic acid;Ethyl 3-chloro-2,4,5-trifluorobenzoylacetate;5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde;2-(Bromomethyl)-5-(trifluoromethyl)furan;Methyl 4-amino-2-methoxybenzoate;2-Amino-5-bromobenzoic acid;2-Chloro-6-methylaniline;L-Alanine isopropyl ester hydrochloride;2-Bromo-5-chlorobenzoic acid;5-Bromo-2-iodobenzoic acid;N-Acetyl-L-tyrosinamide;(1S,2S,3R,5S)-(+)-2,3-Pinanediol

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E7D42

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;CMO & CRO;Biotech